In cancer, sustained CCL5-mediated inflammation leads to a suppressive environment via attraction of CCR5+ immunoregulatory components including Tregs, tumor-associated macrophages (TAMs), and myeloid-derived suppressor cells (MDSCs) normally involved in resolving inflammatory events (Hemmatazad and Berger, 2021). Here, CCL5 is linked to neoplasm.